Daniela Carl, incoming CEO of the Guidelines International Network, is a senior leader with extensive experience in global research, education and membership institutions.

Passionate about supporting communities and driving positive change, she specializes in organizational growth, strategic planning, stakeholder engagement, and digital innovation. With a strong commitment to sustainability, equity, and inclusion, she has led transformational initiatives that have strengthened engagement, diversified income streams, and built global impact.

Roberta James is the Programme Lead at the Scottish Intercollegiate Guidelines Network (SIGN), which is part of Healthcare Improvement Scotland. She has responsibility for the currency, quality, validity and timely development and dissemination of SIGN guidelines. With 20 years of experience producing evidence-based guidelines at SIGN, she is interested in presenting recommendations in ways that fit the needs of professional and public audiences. Roberta is Vice-Chair of the Guideline International Network (GIN) Board of Trustees and a member of its Implementation working group. Roberta started her career as a research scientist after undergraduate and postgraduate study at Edinburgh University and before joining SIGN spent 10 years as a research scientist at the Medical Research Council Human Genetics Unit in Edinburgh, the Roslin Institute and the Cancer Research UK labs at the University of Edinburgh.

Robby Nieuwlaat is Associate Professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University. He obtained MSc in health sciences (2001) and PhD in cardiovascular clinical epidemiology (2007) from Maastricht University in The Netherlands. He worked as a post-doctoral research fellow at the Population Health Research Institute in Hamilton from 2008 until becoming a faculty member at McMaster University in 2011. He is a researcher in the MacGRADE Centre of McMaster University, GRADE working group member, and has experience with developing practice guidelines as a methodology panel member and systematic review lead. He is also a researcher at the Michael G. DeGroote Cochrane Canada Centre at McMaster University, Cochrane Heart editorial board member, and has led several highly cited reviews. His research interests include advancing evidence synthesis methods for clinical decision-making, as well as optimizing implementation of recommended best practice. He is an author of over 100 peer-reviewed publications (h-index 41 in Google scholar).